1. Home
  2. IBCP vs IRWD Comparison

IBCP vs IRWD Comparison

Compare IBCP & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independent Bank Corporation

IBCP

Independent Bank Corporation

HOLD

Current Price

$35.48

Market Cap

829.6M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.28

Market Cap

713.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBCP
IRWD
Founded
1864
1998
Country
United States
United States
Employees
270
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
829.6M
713.8M
IPO Year
2010
2009

Fundamental Metrics

Financial Performance
Metric
IBCP
IRWD
Price
$35.48
$4.28
Analyst Decision
Hold
Buy
Analyst Count
2
3
Target Price
$37.00
$7.67
AVG Volume (30 Days)
127.2K
1.6M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.35%
N/A
EPS Growth
3.48
1400.00
EPS
1.72
0.55
Revenue
$32,075,000.00
$298,276,000.00
Revenue This Year
N/A
$57.95
Revenue Next Year
$8.98
$4.39
P/E Ratio
$20.71
$8.34
Revenue Growth
0.30
8.88
52 Week Low
$29.83
$1.26
52 Week High
$39.24
$5.78

Technical Indicators

Market Signals
Indicator
IBCP
IRWD
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
IBCP
IRWD

About IBCP Independent Bank Corporation

Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: